ArticleOdontology2026
Coupling osteogenesis and angiogenesis with controlled osteoclastogenesis: a multifunctional graphene oxide-modified CFR-PEEK implant.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Achieving rapid osseointegration while preventing bacterial infection remains a critical challenge in dental implantology. In this study, we developed a multifunctional interface on carbon fiber-reinforced polyetheretherketone (Cpeek) by combining a sulfurized porous structure with a graphene oxide (GO) coating (Gcpeek). In vitro evaluations were conducted to assess its osteogenic, immunomodulatory, osteoclastic, angiogenic, and antibacterial properties. Results demonstrated that the Gcpeek surface significantly upregulated the expression of key osteogenic genes (e.g., ALP, RUNX2, COL-1) in MC3T3-E1 pre-osteoblasts. Mechanistically, while the physical roughness of the Scpeek porous structure inadvertently triggered pro-inflammatory M1 macrophage polarization and subsequent osteoclast differentiation, the GO coating on Gcpeek effectively reversed this trend. It actively steered macrophages toward an anti-inflammatory M2 phenotype (upregulating Arg-1 and CD206), which subsequently downregulated osteoclast markers (MMP9, TRAP) and inhibited excessive resorption. Additionally, Gcpeek promoted angiogenesis in HUVECs by enhancing VEGF and ANG-1 expression, and exhibited strong antimicrobial activity against Staphylococcus aureus and Porphyromonas gingivalis. In conclusion, these in vitro findings suggest that the GO-modified Gcpeek surface provides a promising dual-action effect. By driving M2 macrophage polarization, it effectively neutralizes the osteoclastogenic risk posed by rough substrates while concurrently supporting osteogenesis, vascularization, and infection control, highlighting its functional potential for peri-implant bone repair.
Indexed as
Identifiers
42230426What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.